dydrogesterone has been researched along with drospirenone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colacurci, N; De Franciscis, P; Leo, S; Paolisso, G; Rizzo, MR | 1 |
| Cai, G; Gu, M; Li, X; Mueck, AO; Ruan, X; Wang, L; Zhao, Y | 1 |
1 trial(s) available for dydrogesterone and drospirenone
| Article | Year |
|---|---|
Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome.
Topics: Administration, Oral; Androstenes; Anthropometry; Biomarkers; Blood Glucose; Dydrogesterone; Estrogens; Female; Humans; Inflammation; Insulin; Lipids; Metabolic Syndrome; Middle Aged; Mineralocorticoid Receptor Antagonists; Postmenopause; Progestins; Prospective Studies; Treatment Outcome | 2014 |
1 other study(ies) available for dydrogesterone and drospirenone
| Article | Year |
|---|---|
Progestogens and PGRMC1-dependent breast cancer tumor growth: An in-vitro and xenograft study.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Proliferation; Cyproterone Acetate; Dydrogesterone; Estradiol; Female; Heterografts; Humans; In Vitro Techniques; MCF-7 Cells; Megestrol; Membrane Proteins; Mice; Mice, Nude; Nandrolone; Norethindrone; Progesterone; Progestins; Prospective Studies; Receptors, Progesterone | 2019 |